Cubist Systematic Strategies’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$9.67M Buy
22,700
+17,600
+345% +$6.82M 0.05% 587
2025
Q2
$1.95M Sell
5,100
-11,500
-69% -$4.14M 0.01% 1581
2025
Q1
$5.74M Buy
16,600
+2,700
+19% +$868K 0.03% 799
2024
Q4
$4.17M Buy
13,900
+10,500
+309% +$3.67M 0.03% 942
2024
Q3
$1.38M Buy
3,400
+2,500
+278% +$915K 0.01% 1623
2024
Q2
$289K Sell
900
-8,400
-90% -$2.73M ﹤0.01% 2373
2024
Q1
$3.1M Buy
9,300
+800
+9% +$244K 0.02% 1305
2023
Q4
$2.3M Hold
8,500
0.02% 1410
2023
Q3
$2.09M Sell
8,500
-800
-9% -$219K 0.02% 1336
2023
Q2
$2.82M Sell
9,300
-9,400
-50% -$2.61M 0.02% 1231
2023
Q1
$4.93M Buy
18,700
+10,200
+120% +$2.59M 0.03% 943
2022
Q4
$2.04M Hold
8,500
0.01% 1849
2022
Q3
$1.56M Buy
+8,500
New +$1.69M 0.01% 2239

Other funds holding HCA

Cubist Systematic Strategies's HCA Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of HCA Healthcare (HCA) in Q2 2024, closing a stake of 18,329 shares — an estimated $5.96M sold.

Cubist Systematic Strategies first reported a position in HCA in Q2 2014 and held it in 38 quarters. The position peaked at $25.1M in Q2 2022. 1,156 funds tracked by Wall St. Rank hold HCA as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining HCA Healthcare position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 18,329 HCA Healthcare shares in Q2 2024, an estimated $5.96M.
  • Cubist Systematic Strategies first reported a position in HCA Healthcare in Q2 2014 and held it in 38 quarters.
  • Cubist Systematic Strategies's HCA Healthcare position peaked at $25.1M in Q2 2022.
  • 1,156 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.